Ezio Giorda

6PUBLICATIONS
75CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Metabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Proteasome inhibition promotes Foxn1 expression in thymic epithelial cells and induces thymic regeneration in mice.

Shirley Genah, Marsha Pellegrino, Manuela Giansanti

|Oct 03, 2025
The PP2A-B55α phosphatase is a master regulator of mitochondrial degradation and biogenesis.

Valentina Cianfanelli, Monica Nanni, Samantha Corrà

|Mar 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma.

Roselia Ciccone, Concetta Quintarelli, Antonio Camera

|Jan 11, 2022
Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes.

Andrea Arena, Eugenia Belcastro, Antonella Accardo

|Sep 18, 2020
Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG.

Giulia Pericoli, Stefania Petrini, Ezio Giorda

|Jun 26, 2020
Phosphoinositide-specific phospholipase C isoforms are conveyed by osteosarcoma-derived extracellular vesicles.

Enrica Urciuoli, Martina Leopizzi, Valeria Di Maio

Pageof 1